Pramod Kumar

Employment

• Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit Scientist
  2018 - Present
• Helmholtz Zentrum München Scientist
  2017 - 2018
• University of Nottingham Cascade Fellows: Marie Curie Research Fellow
  2015 - 2017
• Bioplus Life Sciences Pvt Ltd Junior Scientist
  2008 - 2009

Education

• National University of Ireland - Galway Ph.D.
  2010 - 2015
• Dr Hari Singh Gour University M. Pharm.
  2005 - 2008
• Dr Hari Singh Gour University B. Pharm
  ? - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• A composite Gelatin/hyaluronic acid hydrogel as an ECM mimic for developing mesenchymal stem cell‐derived epithelial tissue patches
  2019
  +Save
• Prospects and challenges in engineering functional respiratory epithelium for in vitro and in vivo applications
  2017
  +Save
• Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis
  Scientific Reports 2016
  +Save
• Progress in Corneal Stromal Repair: From Tissue Grafts and Biomaterials to Modular Supramolecular Tissue‐Like Assemblies
  Advanced Materials 2016
  +Save
• Low, but not too low, oxygen tension and macromolecular crowding accelerate extracellular matrix deposition in human dermal fibroblast culture
  Acta Biomaterialia 2016
  +Save
• Accelerated Development of Supramolecular Corneal Stromal-Like Assemblies from Corneal Fibroblasts in the Presence of Macromolecular Crowders
  Tissue Engineering - Part C: Methods 2015 DOI: 10.1089/ten.tec.2014.0387
  +Save
• Macromolecularly crowded in vitro microenvironments accelerate the production of extracellular matrix-rich supramolecular assemblies
  Scientific Reports 2015 DOI: 10.1038/srep08729
  +Save
• Macromolecular crowding meets tissue engineering by self-assembly: A paradigm shift in regenerative medicine
  Advanced Materials 2014 DOI: 10.1002/adma.201304428
  +Save
• Engineering in vitro microenvironments for cell based therapies and drug discovery
  Drug Discovery Today 2013 DOI: 10.1016/j.drudis.2013.06.007
  +Save
• Liposomes a vesicular nanocarrier: Potential advancements in cancer chemotherapy
  Critical Reviews in Therapeutic Drug Carrier Systems 2012 DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i5.10
  +Save